Primary analysis of the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE trial of RP1 plus nivolumab, including clinical subgroup and initial biomarker data

Abstract

Open access

Peer reviewed

E Muñoz Couselo, C Robert, P.K. Bommareddy, M.R. Middleton, M.M. Milhem, J.J. Sacco, J. Michels, G.K. In, D. Schadendorf, G.M. Beasley, …

EJC skin cancer, Vol.3(Supplement 1), 100617

2025

DOI: 10.1016/j.ejcskn.2025.100617

Files and links (1)

url

https://doi.org/10.1016/j.ejcskn.2025.100617View

Published (Version of record) Open Access

Title: Subtitle: Primary analysis of the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE trial of RP1 plus nivolumab, including clinical subgroup and initial biomarker data
Creators: E Muñoz Couselo
C Robert
P.K. Bommareddy
M.R. Middleton
M.M. Milhem
J.J. Sacco
J. Michels
G.K. In
D. Schadendorf
G.M. Beasley
J. Niu
B. Chmielowski
T.M. Wise-Draper
T.L. Bowles
K.K. Tsai
C. Lebbé
C. Gaudy-Marqueste
A. Samson
J A Chesney
A.M. VanderWalde
M. Viana
C. Tucci
T. Liu
L. Donthireddy
A. Monteagudo
J. Zhu
J.W. Hou
M.K. Wong
Resource Type: Abstract
Publication Details: EJC skin cancer, Vol.3(Supplement 1), 100617
DOI: 10.1016/j.ejcskn.2025.100617
ISSN: 2772-6118
eISSN: 2772-6118
Language: English
Date published: 2025
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984808275602771

12 Record Views